ABCL
Price
$4.30
Change
-$0.09 (-2.05%)
Updated
Aug 25, 03:13 PM (EDT)
Capitalization
1.31B
78 days until earnings call
VCYT
Price
$29.87
Change
-$1.13 (-3.65%)
Updated
Aug 25, 12:57 PM (EDT)
Capitalization
2.44B
78 days until earnings call
Interact to see
Advertisement

ABCL vs VCYT

Header iconABCL vs VCYT Comparison
Open Charts ABCL vs VCYTBanner chart's image
AbCellera Biologics
Price$4.30
Change-$0.09 (-2.05%)
Volume$100
Capitalization1.31B
Veracyte
Price$29.87
Change-$1.13 (-3.65%)
Volume$300
Capitalization2.44B
ABCL vs VCYT Comparison Chart in %
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. VCYT commentary
Aug 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and VCYT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 25, 2025
Stock price -- (ABCL: $4.39 vs. VCYT: $31.00)
Brand notoriety: ABCL and VCYT are both not notable
ABCL represents the Biotechnology, while VCYT is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ABCL: 65% vs. VCYT: 67%
Market capitalization -- ABCL: $1.31B vs. VCYT: $2.44B
ABCL [@Biotechnology] is valued at $1.31B. VCYT’s [@Medical Specialties] market capitalization is $2.44B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.31B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B. The average market capitalization across the [@Medical Specialties] industry is $10.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than VCYT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while VCYT’s TA Score has 6 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 4 bearish.
  • VCYT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VCYT is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а -4.36% price change this week, while VCYT (@Medical Specialties) price change was +2.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.64%. For the same industry, the average monthly price growth was +19.31%, and the average quarterly price growth was +29.97%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.19%. For the same industry, the average monthly price growth was +15.22%, and the average quarterly price growth was +7.32%.

Reported Earning Dates

ABCL is expected to report earnings on Nov 11, 2025.

VCYT is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.64% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical Specialties (+0.19% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCYT($2.44B) has a higher market cap than ABCL($1.31B). ABCL YTD gains are higher at: 49.829 vs. VCYT (-21.717). VCYT has higher annual earnings (EBITDA): 52M vs. ABCL (-197.92M). ABCL has more cash in the bank: 553M vs. VCYT (321M). VCYT has less debt than ABCL: VCYT (50.6M) vs ABCL (142M). VCYT has higher revenues than ABCL: VCYT (479M) vs ABCL (32.9M).
ABCLVCYTABCL / VCYT
Capitalization1.31B2.44B54%
EBITDA-197.92M52M-381%
Gain YTD49.829-21.717-229%
P/E RatioN/A91.18-
Revenue32.9M479M7%
Total Cash553M321M172%
Total Debt142M50.6M281%
FUNDAMENTALS RATINGS
VCYT: Fundamental Ratings
VCYT
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
95
SMR RATING
1..100
88
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
74
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLVCYT
RSI
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
89%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
75%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
79%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 13 days ago
72%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 5 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 4 days ago
83%
Aroon
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VTSIX96.943.55
+3.80%
Vanguard Tax-Managed Small Cap I
CTOGX16.340.44
+2.77%
Calamos Timpani SMID Growth R6
JEEFX16.930.15
+0.89%
JHancock Infrastructure C
FTANX12.530.10
+0.80%
Fidelity Asset Manager 30%
PMIAX11.070.08
+0.73%
Putnam Multi-Asset Income A